Celiac disease

被引:8
作者
Ahmad S. Abdulkarim
Joseph A. Murray
机构
[1] Mayo Clinic,Division of Gastroenterology and Hepatology
关键词
Celiac Disease; Coeliac Disease; Villous Atrophy; Small Bowel Disease; Celiac Sprue;
D O I
10.1007/s11938-002-0004-3
中图分类号
学科分类号
摘要
Individuals with celiac disease present with a wide array of symptoms and signs. Celiac disease can result in substantial injury to the small intestine, deleterious effects on other organ systems, and an overall doubling of mortality. The role of the gastroenterologist is primarily to make the diagnosis and then to ensure that patients with celiac disease receive up-to-date and accurate instructions on diet. It is our opinion that gastroenterologists should participate in the follow-up of what is in fact a form of inflammatory bowel disease. The failure to identify and treat patients with substantial problems may result in an excess of preventable morbidity and mortality.Intestinal biopsy is the definitive method of making the diagnosis of celiac disease, provided the patient has not excluded gluten from his or her diet, because exclusion of gluten results in negative serologic test results and normal small intestinal biopsy samples.The removal of gluten from the diet can result in a total recovery of gut function and a correction of most other consequences. The response is usually so complete that patients should consider themselves to be basically healthy as long as they stay away from the offending foods. However, the execution and maintenance of the “theoretically simple” exclusion of gluten is difficult. The condition is permanent and mandates adherence to a lifelong gluten-free diet; even small amounts of gluten can result in injury to the intestinal lining. The diet is restrictive and requires the patient to be careful about food choices. Therefore, patient education and motivation are crucial to a successful outcome.The correction of vitamin and mineral deficiencies may be helpful in aiding recovery; vitamin D and calcium supplementation often is recommended.No drug therapy has been proven to suppress the disease.
引用
收藏
页码:27 / 38
页数:11
相关论文
共 104 条
[1]  
Lundin KE(1993)Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients J Exp Med 178 187-196
[2]  
Scott H(2000)In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope Nat Med 6 337-342
[3]  
Hansen T(1960)Studies of celiac disease: the apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue Gastroenterology 38 28-28
[4]  
Anderson RP(1994)Epidemiology of celiac sprue: a community-based study Am J Gastroenterol 89 843-846
[5]  
Degano P(1998)Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors Scand J Gastroenterol 33 494-498
[6]  
Godkin AJ(2001)Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum Gastroenterology 120 636-651
[7]  
Rubin CE(1997)Celiac disease in an adult population with insulin-dependent diabetes mellitus: use of endomysial antibody testing Am J Gastroenterol 92 1280-1284
[8]  
Brandborg LL(2001)Coeliac disease in the father affects the newborn Gut 49 169-175
[9]  
Phelps PC(1999)Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease Gastroenterology 117 297-303
[10]  
Talley NJ(1998)Diagnosis of gluten-sensitive enteropathy: is exclusive reliance on histology appropriate? Eur J Gastroenterol Hepatol 10 919-925